Panagora Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
WA
NAMA
AIM
Panagora Asset Management's INO Position: Q4 2019 in Review
Panagora Asset Management sold out of Inovio Pharmaceuticals (INO) in Q4 2019, closing a stake of 4,752 shares — an estimated $117K sold.
Panagora Asset Management first reported a position in INO in Q2 2015 and held it in 18 quarters. The position peaked at $5.92M in Q2 2017. 106 funds tracked by Wall St. Rank hold INO as of Q4 2019.
- Panagora Asset Management reported no remaining Inovio Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Panagora Asset Management sold 4,752 Inovio Pharmaceuticals shares in Q4 2019, an estimated $117K.
- Panagora Asset Management first reported a position in Inovio Pharmaceuticals in Q2 2015 and held it in 18 quarters.
- Panagora Asset Management's Inovio Pharmaceuticals position peaked at $5.92M in Q2 2017.
- 106 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2019.
Based on Panagora Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.